Coya Therapeutics, Inc.
COYANasdaqCIK 1835022HealthcareFiscal year ends Dec 31
Reports and events: 79 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1412:30 ET | 8-K | 8.01 Other events | 0001193125-26-421066 |
| 2026-10-0512:30 ET | 8-K | 8.01 Other events | 0001193125-26-413218 |
| 2026-09-1512:15 ET | 8-K | 8.01 Other events | 0001193125-26-391378 |
| 2026-08-1112:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-343481 |
| 2026-08-1112:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-343473 |
| 2026-08-0721:00 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001193125-26-340449 |
| 2026-06-2521:00 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-282989 |
| 2026-05-1312:30 ET | DEF 14A | Proxy statementPeriod 2026-06-25 | 0001193125-26-220688 |
| 2026-05-1212:48 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-218282 |
| 2026-05-1211:41 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-218201 |
| 2026-05-1211:39 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-218198 |
| 2026-04-0212:48 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-139094 |
| 2026-03-1612:11 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-107281 |
| 2026-03-1612:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-107276 |
| 2026-01-3013:06 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-030531 |
| 2026-01-2013:20 ET | 8-K | 8.01 Other events | 0001193125-26-016017 |
| 2026-01-0813:10 ET | 8-K | 8.01 Other events | 0001193125-26-007042 |
| 2025-12-1713:00 ET | 8-K | 8.01 Other events | 0001193125-25-321737 |
| 2025-11-1213:13 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-276058 |
| 2025-11-1213:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-276022 |
| 2025-10-2711:36 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-250709 |
| 2025-09-0212:30 ET | 8-K | 8.01 Other events | 0001193125-25-193450 |
| 2025-08-1212:08 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-106934 |
| 2025-08-1212:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-106932 |
| 2025-07-2921:10 ET | 8-K | 8.01 Other events | 0001193125-25-168115 |
| 2025-07-0112:00 ET | 8-K | 8.01 Other events | 0001193125-25-153465 |
| 2025-06-2621:00 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-149104 |
| 2025-05-1621:01 ET | DEF 14A | Proxy statementPeriod 2025-06-26 | 0001193125-25-121779 |
| 2025-05-1312:14 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-069824 |
| 2025-05-1312:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-069819 |
| 2025-04-2821:07 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001193125-25-100816 |
| 2025-03-1812:26 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-040782 |
| 2025-03-1812:20 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-040779 |
| 2024-11-0613:06 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-121837 |
| 2024-11-0613:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-121833 |
| 2024-11-0522:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-251319 |
| 2024-10-3120:42 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-248755 |
| 2024-10-2912:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-246171 |
| 2024-10-2213:08 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-240775 |
| 2024-08-1913:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-202551 |
| 2024-08-1212:13 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-095075 |
| 2024-08-1212:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-095072 |
| 2024-07-1510:10 ET | 8-K | 8.01 Other events | 0001193125-24-178809 |
| 2024-06-0512:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-154729 |
| 2024-05-2021:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-142950 |
| 2024-05-0920:26 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-057056 |
| 2024-05-0920:20 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-057018 |
| 2024-05-0821:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-134376 |
| 2024-03-2820:30 ET | DEF 14A | Proxy statementPeriod 2024-05-08 | 0000950170-24-038090 |
| 2024-03-1912:27 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-033161 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.